NVO logo

Novo Nordisk A/S (NVO) Cash From Financing

Annual CFF:

$1.27B+$10.43B(+113.82%)
December 31, 2024

Summary

  • As of today, NVO annual cash from financing is $1.27 billion, with the most recent change of +$10.43 billion (+113.82%) on December 31, 2024.
  • During the last 3 years, NVO annual cash from financing has risen by +$5.32 billion (+131.27%).
  • NVO annual cash from financing is now at all-time high.

Performance

NVO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Quarterly CFF:

-$3.85B-$1.77B(-84.71%)
June 1, 2025

Summary

  • As of today, NVO quarterly cash from financing is -$3.85 billion, with the most recent change of -$1.77 billion (-84.71%) on June 1, 2025.
  • Over the past year, NVO quarterly cash from financing has dropped by -$6.29 billion (-258.33%).
  • NVO quarterly cash from financing is now -171.88% below its all-time high of $5.36 billion, reached on December 31, 2024.

Performance

NVO Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

TTM CFF:

-$3.27B-$6.29B(-208.26%)
June 1, 2025

Summary

  • As of today, NVO TTM cash from financing is -$3.27 billion, with the most recent change of -$6.29 billion (-208.26%) on June 1, 2025.
  • Over the past year, NVO TTM cash from financing has increased by +$2.48 billion (+43.14%).
  • NVO TTM cash from financing is now -208.26% below its all-time high of $3.02 billion, reached on March 31, 2025.

Performance

NVO TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NVO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+113.8%-258.3%+43.1%
3Y3 Years+131.3%-164.8%+39.7%
5Y5 Years+123.8%-239.7%+41.1%

NVO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+113.8%-171.9%at low-208.3%+67.4%
5Y5-Yearat high+113.8%-171.9%at low-208.3%+67.4%
All-TimeAll-Timeat high+113.8%-171.9%at low-208.3%+67.4%

NVO Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$3.85B(-84.7%)
-$3.27B(-208.3%)
Mar 2025
-
-$2.09B(-138.9%)
$3.02B(+138.4%)
Dec 2024
$1.27B(+113.8%)
$5.36B(+299.3%)
$1.27B(+122.8%)
Sep 2024
-
-$2.69B(-210.5%)
-$5.56B(+3.2%)
Jun 2024
-
$2.43B(+163.4%)
-$5.75B(+42.7%)
Mar 2024
-
-$3.84B(-161.6%)
-$10.03B(-9.5%)
Dec 2023
-$9.16B(-25.2%)
-$1.47B(+49.0%)
-$9.16B(-5.6%)
Sep 2023
-
-$2.88B(-55.8%)
-$8.68B(-11.3%)
Jun 2023
-
-$1.85B(+37.9%)
-$7.80B(-5.3%)
Mar 2023
-
-$2.97B(-203.5%)
-$7.40B(-1.2%)
Dec 2022
-$7.32B(-80.6%)
-$979.52M(+51.0%)
-$7.32B(-31.8%)
Sep 2022
-
-$2.00B(-37.2%)
-$5.55B(-2.3%)
Jun 2022
-
-$1.46B(+49.5%)
-$5.43B(-18.1%)
Mar 2022
-
-$2.89B(-466.3%)
-$4.59B(-13.3%)
Dec 2021
-$4.05B(+17.8%)
$787.58M(+142.1%)
-$4.05B(+18.5%)
Sep 2021
-
-$1.87B(-200.6%)
-$4.97B(-4.2%)
Jun 2021
-
-$622.81M(+73.4%)
-$4.77B(+9.7%)
Mar 2021
-
-$2.34B(-1650.3%)
-$5.28B(-7.1%)
Dec 2020
-$4.93B(+7.3%)
-$133.94M(+92.0%)
-$4.93B(+11.2%)
Sep 2020
-
-$1.67B(-47.2%)
-$5.55B(-3.2%)
Jun 2020
-
-$1.13B(+43.0%)
-$5.38B(-2.4%)
Mar 2020
-
-$1.99B(-163.3%)
-$5.25B(+1.2%)
Dec 2019
-$5.32B(+2.6%)
-$756.47M(+49.4%)
-$5.32B(-3.0%)
Sep 2019
-
-$1.50B(-48.2%)
-$5.17B(+3.5%)
Jun 2019
-
-$1.01B(+50.9%)
-$5.36B(-3.2%)
Mar 2019
-
-$2.06B(-241.1%)
-$5.19B(+5.0%)
Dec 2018
-$5.46B(-1.0%)
-$603.29M(+64.2%)
-$5.46B(+3.2%)
Sep 2018
-
-$1.68B(-99.9%)
-$5.65B(+1.9%)
Jun 2018
-
-$842.92M(+63.9%)
-$5.75B(+0.4%)
Mar 2018
-
-$2.33B(-196.6%)
-$5.78B(-6.8%)
Dec 2017
-$5.41B(+6.3%)
-$786.65M(+56.1%)
-$5.41B(-4.0%)
Sep 2017
-
-$1.79B(-106.8%)
-$5.20B(-2.5%)
Jun 2017
-
-$866.27M(+56.0%)
-$5.08B(+2.5%)
Mar 2017
-
-$1.97B(-240.0%)
-$5.21B(+9.9%)
Dec 2016
-$5.78B(-29.1%)
-$578.73M(+65.2%)
-$5.78B(+0.4%)
Sep 2016
-
-$1.67B(-67.2%)
-$5.80B(-18.0%)
Jun 2016
-
-$995.91M(+60.8%)
-$4.92B(-1.5%)
Mar 2016
-
-$2.54B(-319.6%)
-$4.85B(-8.3%)
Dec 2015
-$4.48B(+5.2%)
-$604.80M(+22.5%)
-$4.48B(-0.1%)
Sep 2015
-
-$779.96M(+15.5%)
-$4.47B(-2.2%)
Jun 2015
-
-$922.92M(+57.4%)
-$4.38B(+2.1%)
Mar 2015
-
-$2.17B(-260.6%)
-$4.47B(+5.3%)
Dec 2014
-$4.72B(-12.2%)
-$601.03M(+12.2%)
-$4.72B(-0.7%)
Sep 2014
-
-$684.25M(+32.7%)
-$4.69B(-3.9%)
Jun 2014
-
-$1.02B(+58.0%)
-$4.51B(+4.1%)
Mar 2014
-
-$2.42B(-325.3%)
-$4.71B(-11.8%)
Dec 2013
-$4.21B(-21.1%)
-$568.88M(-12.0%)
-$4.21B(-7.0%)
Sep 2013
-
-$507.77M(+58.0%)
-$3.93B(-5.2%)
Jun 2013
-
-$1.21B(+37.1%)
-$3.74B(-5.8%)
Mar 2013
-
-$1.92B(-553.2%)
-$3.53B(-1.7%)
Dec 2012
-$3.48B(-10.8%)
-$294.26M(+6.0%)
-$3.48B(+6.7%)
Sep 2012
-
-$313.00M(+68.8%)
-$3.72B(+13.7%)
Jun 2012
-
-$1.00B(+46.1%)
-$4.32B(-16.1%)
Mar 2012
-
-$1.86B(-243.0%)
-$3.72B(-18.5%)
Dec 2011
-$3.14B
-$543.28M(+40.0%)
-$3.14B(-9.9%)
DateAnnualQuarterlyTTM
Sep 2011
-
-$904.87M(-123.1%)
-$2.85B(-5.9%)
Jun 2011
-
-$405.52M(+68.4%)
-$2.70B(-3.5%)
Mar 2011
-
-$1.28B(-390.3%)
-$2.60B(-10.8%)
Dec 2010
-$2.35B(-25.2%)
-$261.61M(+64.9%)
-$2.35B(+2.4%)
Sep 2010
-
-$745.40M(-137.9%)
-$2.41B(-10.9%)
Jun 2010
-
-$313.37M(+69.5%)
-$2.17B(-2.3%)
Mar 2010
-
-$1.03B(-222.9%)
-$2.12B(-13.0%)
Dec 2009
-$1.88B(-29.7%)
-$318.61M(+37.4%)
-$1.88B(-7.1%)
Sep 2009
-
-$508.59M(-92.5%)
-$1.75B(-7.6%)
Jun 2009
-
-$264.23M(+66.3%)
-$1.63B(-4.7%)
Mar 2009
-
-$784.28M(-304.7%)
-$1.55B(-7.4%)
Dec 2008
-$1.45B(-15.2%)
-$193.77M(+49.6%)
-$1.45B(+12.5%)
Sep 2008
-
-$384.30M(-101.1%)
-$1.65B(+5.3%)
Jun 2008
-
-$191.07M(+71.8%)
-$1.74B(-11.7%)
Mar 2008
-
-$677.27M(-69.1%)
-$1.56B(-24.4%)
Dec 2007
-$1.26B(-56.8%)
-$400.52M(+15.9%)
-$1.26B(-47.3%)
Sep 2007
-
-$475.97M(-6099.4%)
-$852.47M(-10.2%)
Jun 2007
-
-$7.68M(+97.9%)
-$773.49M(+3.7%)
Mar 2007
-
-$371.18M(>-9900.0%)
-$803.36M(-0.3%)
Dec 2006
-$800.66M(-8.3%)
$2.36M(+100.6%)
-$800.66M(+3.9%)
Sep 2006
-
-$397.00M(-957.3%)
-$833.07M(-41.1%)
Jun 2006
-
-$37.55M(+89.8%)
-$590.33M(+25.2%)
Mar 2006
-
-$368.47M(-1126.3%)
-$789.31M(-6.8%)
Dec 2005
-$739.23M(-28.2%)
-$30.05M(+80.5%)
-$739.23M(+9.7%)
Sep 2005
-
-$154.26M(+34.8%)
-$818.19M(-6.5%)
Jun 2005
-
-$236.52M(+25.7%)
-$768.46M(-29.9%)
Mar 2005
-
-$318.40M(-192.1%)
-$591.53M(-2.6%)
Dec 2004
-$576.43M(-58.3%)
-$109.00M(-4.3%)
-$576.43M(-23.3%)
Sep 2004
-
-$104.54M(-75.4%)
-$467.42M(-28.8%)
Jun 2004
-
-$59.59M(+80.4%)
-$362.88M(-19.6%)
Mar 2004
-
-$303.29M
-$303.29M
Dec 2003
-$364.11M(-88.0%)
-
-
Dec 2002
-$193.65M(-70.7%)
-
-
Dec 2001
-$113.44M(+57.3%)
-
-
Dec 2000
-$265.87M(-2410.5%)
-
-
Dec 1999
-$10.59M(+97.4%)
-
-
Dec 1998
-$399.94M(-613.0%)
-
-
Dec 1997
$77.97M(+161.7%)
-
-
Dec 1996
-$126.43M(+59.5%)
-
-
Dec 1995
-$312.48M(-370.2%)
-
-
Dec 1994
$115.66M(+125.2%)
-
-
Dec 1993
$51.35M(-20.7%)
-
-
Dec 1992
$64.74M(-76.7%)
-
-
Dec 1991
$277.77M(+909.7%)
-
-
Dec 1990
-$34.31M(-224.6%)
-
-
Dec 1989
$27.53M(+128.8%)
-
-
Dec 1988
$12.03M(+180.9%)
-
-
Dec 1987
-$14.88M(-18.0%)
-
-
Dec 1986
-$12.61M(-30.9%)
-
-
Dec 1985
-$9.64M(+1.5%)
-
-
Dec 1984
-$9.78M(+10.7%)
-
-
Dec 1983
-$10.96M(-18.1%)
-
-
Dec 1982
-$9.27M(+2.6%)
-
-
Dec 1981
-$9.52M(-37.4%)
-
-
Dec 1980
-$6.92M
-
-

FAQ

  • What is Novo Nordisk A/S annual cash from financing?
  • What is the all-time high annual cash from financing for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual cash from financing year-on-year change?
  • What is Novo Nordisk A/S quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly cash from financing year-on-year change?
  • What is Novo Nordisk A/S TTM cash from financing?
  • What is the all-time high TTM cash from financing for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM cash from financing year-on-year change?

What is Novo Nordisk A/S annual cash from financing?

The current annual cash from financing of NVO is $1.27B

What is the all-time high annual cash from financing for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cash from financing is $1.27B

What is Novo Nordisk A/S annual cash from financing year-on-year change?

Over the past year, NVO annual cash from financing has changed by +$10.43B (+113.82%)

What is Novo Nordisk A/S quarterly cash from financing?

The current quarterly cash from financing of NVO is -$3.85B

What is the all-time high quarterly cash from financing for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cash from financing is $5.36B

What is Novo Nordisk A/S quarterly cash from financing year-on-year change?

Over the past year, NVO quarterly cash from financing has changed by -$6.29B (-258.33%)

What is Novo Nordisk A/S TTM cash from financing?

The current TTM cash from financing of NVO is -$3.27B

What is the all-time high TTM cash from financing for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cash from financing is $3.02B

What is Novo Nordisk A/S TTM cash from financing year-on-year change?

Over the past year, NVO TTM cash from financing has changed by +$2.48B (+43.14%)
On this page